Restech | Mederi-RF is pleased to announce that Restech diagnostic testing has come to South Africa and Namibia through a distribution agreement with Tactus Trading (PTY) LTD.
Continuing our rapid growth in 2019, Restech | Mederi-RF is pleased to announce a distribution agreement with Innovamedica S.P.A.
After a busy holiday season, many of us start the new year wondering what we can do to resolve our reflux. Overindulgence in food and drink during prolonged periods of sitting can backfire with heartburn and other reflux related symptoms.
As we come together this month to celebrate National COPD Awareness and World COPD Day, it’s worth remembering the complexities that COPD (Chronic Obstructive Pulmonary Disorder) can bring to other diagnoses, especially GERD (Gastro-Esophageal Reflux Disease) and LPR (Laryngo-Pharyngeal Reflux).
A new study on Stretta anti-reflux therapy was recently published in Frontline Gastroenterology, reinforcing the value and safety of Stretta as a viable option for many patients who are unwilling or unable to undergo surgical intervention.
University of Kansas Voice and Swallow Center Director, David Garnett MD, FACS delivers keynote presentation in China: "Hyperacidity and the Irritated Airway"
Andrew Krauss, MS, CCC-SLP is heading to Philly to represent Restech at the Voice Foundation's Annual Symposium. This meeting is an intimate gathering of voice professionals, researchers, and students in otolaryngology, voice science, speech pathology and vocal pedagogy. Restech has supported the meeting for the past decade and we are excited to be there again this year.
Dr. Josef Schlömicher-Thier
Chief of the International Voice Center Austria
Chief of the ENT Center in Neumarkt/Salzburg
CASE HISTORY & EVALUATION
A 60 year old male presented with hoarseness, a heavy cough, and voice problems extending back at least four years. Symptoms had recently exacerbated leaving the individual out of work on sick leave. The patient reported multiple prior pneumonias, but presented with a normal pulmonary exam at the time of the initial assessment.
Prior to his office assessment, the patient was examined at a different hospital. This included the discovery of a minor hiatal hernia, which was accompanied by a negative esophageal manometry test and a negative duel channel pH test. Video Stroboscopy revealed hyperplasia/ leucoplakia. VRP showed a restricted mass.
Houston, TX, 04/24/18: Respiratory Technology Corporation (Restech) announced today the asset acquisition of Mederi Therapeutics Inc. In response to the increasing need for therapeutic options to address the growing conditions of reflux disease and gastric disease, Restech welcomes the addition Stretta® and Secca® technology to their product portfolio. These new innovative product lines complement Restech’s existing diagnostic devices with therapeutic solutions, provide additional clinical pathways, and broaden Restech’s global distribution network.